ServiziMenu principaleHome
You are here: Home > Events > Future Events > ESO-ESMO Baltic and Eurasia Masterclass in Clinical Oncology


Masterclass coordinator: N. Pavlidis, GR
ESO Chair: F. Peccatori, IT
ESMO Chair: F. Lordick, DE
Host Chair: A. Elme, EE

The Masterclass offers plenary lectures discussing current issues and controversies as well as critically reviewing significant therapeutic development. State-of-the-art data recognised by ESMO and other evidence-based guidelines will be cited. Participants will deliver case presentations within tumour board basis and discuss them with the chairs and the faculty. Additional time will be allocated for participants to deliver case presentations within small groups and receive feedback.
As for all Masterclasses, the number of participants will be limited and admission will be by competitive application only.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and at least an intermediate level of English is necessary for admission.

This clinically oriented educational programme is designed for medical, clinical and radiation oncologists who wish to improve their skills in multidisciplinary care management.
The programme will expose participants to a full spectrum of issues in clinical oncology and practice-orientated training focusing on lung, genito-urinary, breast, head-and-neck, gastrointestinal, gynaecological cancers. Spotlight sessions will facilitate compact update on different topics (programme will be published soon).

• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on lung, genito-urinary, breast, head-and-neck, gastrointestinal and gynaecological cancers.

In this review, the authors summarize the history of the 41 Masterclasses in Clinical Oncology (MCO) organized by ESO or ESO-ESMO during the last 17 years. The MCO has become a major educational event of ESO, intending to educate young oncologists from various countries within or outside Europe, providing an up-to-date interactive program based on solid evidence for all presented topics.
"Reprinted from Critical Reviews in Oncology / Hematology, Pavlidis et al, Copyright (2019)
https://doi.org/10.1016/j.critrevonc.2019.07.022 with permission from Elsevier”

Download PDF document


Anne Arber, University of Surrey, Faculty of Health and Medical Sciences, Guildford, UK
Giulia Baciarello, Gustave Roussy Institute, Genitourinary Oncology Dpt., Villejuif, FR
Maria-João Cardoso, Champalimaud Foundation, Breast Unit, Lisbon, PT
Paolo Giovanni Casali, Fondazione IRCCS Istituto Nazionale Tumori, SC Oncologia Medica 2, Milano, IT
Alessandra Curioni-Fontecedro, University Hospital Zurich, CH
Sara De Dosso, Oncology Institute of Southern Switzerland (IOSI), Medical Oncology Dpt., Bellinzona, CH
Anneli Elme, North Estonian Regional Hospital Cancer Centre, Dept. of Chemotherapy, Tallinn, EE
Alexandru Eniu, Riviera-Chablais Vaud-Valais, Interdisciplinary Oncology Service (SIC), Rennaz, CH
Fady B. Geara, American University of Beirut Medical Center, Dept. of Radiation Oncology, Riad El Solh, Beirut, LB
Andrew Hoy, Consultant in Palliative Medicine, Epson, UK
Evgeniya Kharchenko, National Medical Research Center of Oncology n/a Petrov, Innovative Methods of Therapeutic Oncology and Rehabilitation Dpt., St. Petersburg, RU
Florian Lordick, University Hospital Leipzig, University Cancer Center Leipzig (UCCL), Leipzig, DE
Salvador E. Martin Algarra, Clinica Universidad de Navarra, Medical Oncology Dept., Pamplona, Navarra, ES
Tõnis Metsaots, North-Estonia Medical Center, Oncology Dept, Tallinn, EE
Nicolas Mottet, University Jean Monnet, Dept. of Urology, Saint Etienne Cedex 2, FR
Kristiina Ojamaa, East Tallinn Central Hospital, Oncology Dpt., Tallinn, EE
Kersti Oselin, North-Estonia Medical Centre, Oncology Dpt., Tallinn, EE
Olivia Pagani, Geneva University Hospitals, Medical School, Geneva, CH
Demetris Papamichael, Bank of Cyprus Oncology Centre, Medical Oncology Dpt., Nicosia, CY
Nicholas Pavlidis, University Hospital of Ioannina, Medical Oncology Dpt., Ioannina, GR
Fedro Alessandro Peccatori, European Institute of Oncology, Dept. of Fertility and Procreation in Oncology, Milano, IT
Giancarlo Pruneri, National Cancer Institute (INT), Pathology Dpt., Milano, IT
Mikk Saretok, North Estonian Regional Hospital Cancer Centre, Chemotherapy Dpt., Tallinn, EE
Cristiana Sessa, Italian Switzerland Cancer Institute (IOSI), Gynaecology Dpt., Bellinzona, CH
Riccardo Soffietti, University and City of Health and Science Hospital of Turin, Neuro Oncology Dept., Torino, IT
Rolf A. Stahel, University Hospital Zurich, Comprehensive Cancer Center Zurich, Zurich, CH
Anastasios Stathis, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, CH
Christos Toumpanakis, Royal Free Hospital, Centre for Gastroenterology - Neuroendocrine Tumour Unit, London, UK
Jan Baptist Vermorken, Antwerp University Hospital, Medical Oncology Dpt., Edegem, BE
Vanna Zanagnolo, IEO - European Institute of Oncology, Gyneacological Cancer Dpt., Milano, IT

General information

Alice Ciocchini
European School of Oncology (ESO)
Via Turati 29 - 20121 Milan, Italy
Tel: +39 02 85464529
Fax: +39 02 85464545
Email: aciocchini@eso.net


Being selected to take part in an ESO Masterclass is one of the ESO activities that gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.

A Masterclass also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the Masterclass earns participants 30 ESCO credits.
Visit www.esco.org for information on how to join ESCO.

In the event of registrations to events held in partnership with other entities (clearly specified in the title of the event or by sending a request to ESO), please be aware that the partner should be considered joint data controller and that the consents provided to ESO will be transferred to the partner as well. Any subsequent consent modifications will need to be communicated to the partner directly.


Application deadline: 20 March 2021  
Save event date: 07 July 2021  
Early registration by: insert the date  
Late registration by: insert the date  
Onsite registration from: insert the date  


• Age up to 40 years
• At least 2-3 years’ experience in medical or clinical oncology
• This event is designed to meet the educational needs of participants practicing in Baltic and Eurasian countries.
• Involvement in scientific activities
• Intermediate level of English

Interested oncologists should apply online (at the top of this page) providing:

• Letter describing motivation for attending;
• Supporting letter from head of department or mentor;
• CV with list publications (if the list of publications is not provided, it will be assumed that no articles have been
• Clinical case (see below)

Priority will be given to applicants practicing in Baltic and Eurasian countries.

Submit an abstract of one page on the template (form available at the bottom of this page), describing a clinical case related to one of the subjects of the Masterclass (lung, genitourinary, breast, head-and-neck, gastrointestinal and gynaecological cancers). You will have to present your case at the Masterclass in format of a clinical grand round discussion. Please provide straightforward a case of your daily clinical practice - no uncommon or extremely rare cases. A maximum of 10 slides will be permitted containing:

• Diagnostic considerations
• Treatment
• Results, follow-up
• At least three questions proposed for discussion with the faculty

Participants will be asked to bring their personal laptop or tablet (wireless enabled) to the Masterclass as an event dedicated website will be created and all questionnaires and certificates will be accessible only from there. Any potential problems with meeting this request should be communicated to the secretariat as part of the application process.

Successful applicants are granted free registration and half board accommodation

Before you start completing the online application form, please be sure you have all the requested files (CV, Motivation letter, Supporting letter, Professional experience template and Abstract template) ready to be uploaded to the system. Online applications will not be complete unless all the files are uploaded.

• Download HERE your Professional experience template
•  Download HERE your Abstract template


7 July

8:15Welcome Address and brief presentation of ESO and ESMO
Florian Lordick, DE - Nicholas Pavlidis, GR
 8:30Communication Skills Workshop - Group BLUE
Anne Arber, UK
 8:30Communication Skills Workshop - Group RED
Andrew Hoy, UK
 8:30Ethical Issues Workshop - Group YELLOW
 8:30Ethical Issues Workshop - Group GREEN
10:30Coffee break
 11:00Communication Skills Workshop - Group YELLOW
Anne Arber, UK
 11:00Communication Skills Workshop - Group GREEN
Andrew Hoy, UK
 11:00Ethical Issues Workshop - Group BLUE
 11:00Ethical Issues Workshop - Group RED
13:00Lunch with the experts
14:00Clinical session - LUNG CANCER
Kersti Oselin, EE - Rolf A. Stahel, CH
 14:00Multimodality treatment of stage III NSCLC
Fady B. Geara, LB
 14:40Systemic therapy for NSCLC without oncogenic driver mutation
Alessandra Curioni-Fontecedro, CH
 15:20Systemic therapy for NSCLC with oncogenic driver mutation
Rolf A. Stahel, CH
 16:00Systemic treatment to SCLC
Kersti Oselin, EE
16:40Coffee break
18:00Lung cancer clinical case discussion: parallel groups
 18:00Group 1
Alessandra Curioni-Fontecedro, CH - Fady B. Geara, LB
 18:00Group 2
Kersti Oselin, EE - Rolf A. Stahel, CH
20:00Welcome Dinner

8 July

8:30Clinical session - GYNAECOLOGICAL CANCERS
Kristiina Ojamaa, EE - Cristiana Sessa, CH
 9:10Systemic treatment of ovarian cancer
Jan Baptist Vermorken, BE
 9:50Systemic treatment of cervical and endometrial cancer
Cristiana Sessa, CH
 10:30Women in Oncology
Cristiana Sessa, CH
10:40Coffee break
11:10Tumour board - Gyneacological cancers (2 cases)
Kristiina Ojamaa, EE - Cristiana Sessa, CH - Jan Baptist Vermorken, BE
12:00Gyneacological cancer clinical case discussion: parallel groups
 12:00Group 1
Cristiana Sessa, CH
 12:00Group 2
Kristiina Ojamaa, EE - Jan Baptist Vermorken, BE
13:00Lunch with the experts
14:00Clinical session - UROLOGICAL CANCERS
Giulia Baciarello, IT - Mikk Saretok, EE
 14:00Localized prostate cancer
Fady B. Geara, LB
 14:40First line endocrine therapy in endocrine sensitive prostate cancer
Giulia Baciarello, IT
 15:20Treatment of endocrine resistant or refractory prostate cancer
Nicolas Mottet, FR
 16:00Advanced or metastatic renal cancer
Mikk Saretok, EE
16:40Coffee break
17:00Tumor Board on Genitourinary Cancer Cases (4 cases)
Giulia Baciarello, IT - Fady B. Geara, LB - Nicolas Mottet, FR - Mikk Saretok, EE
18:15GU cancer clinical case discussion: parallel groups
 18:15Group 1
Giulia Baciarello, IT - Fady B. Geara, LB
 18:15Group 2
Nicolas Mottet, FR - Mikk Saretok, EE

9 July

8:30Clinical session - BREAST CANCER (part 1)
Tõnis Metsaots, EE - Olivia Pagani, CH
 8:30Molecular diagnostic pathology
Giancarlo Pruneri, IT
 9:10Adjuvant radiotherapy
Fady B. Geara, LB
 9:50Neo and adjuvant chemotherapy and biologicals
Alexandru Eniu, CH
10:30Coffee break
11:00Clinical session - BREAST CANCER (part 2)
Tõnis Metsaots, EE - Olivia Pagani, CH
 11:00Neo and adjuvant endocrine therapy
Olivia Pagani, CH
 11:40Management of HER2+ advanced disease
Alexandru Eniu, CH
 12:20Management of triple negative advanced disease
Evgeniya Kharchenko, RU
13:00Lunch with the experts
14:00Clinical session - BREAST CANCER (part 3)
Tõnis Metsaots, EE - Olivia Pagani, CH
 14:00Management of ER+ advanced disease
Olivia Pagani, CH
 14:40Optimal surgical management of breast cancer
Maria-João Cardoso, PT
15:20Spotlight session - Breast Cancer during pregnancy
Fedro Alessandro Peccatori, IT
15:50Tumor Board on Breast Cancer Cases (4 cases)
Alexandru Eniu, CH - Fady B. Geara, LB - Evgeniya Kharchenko, RU - Tõnis Metsaots, EE - Olivia Pagani, CH - Fedro Alessandro Peccatori, IT - Giancarlo Pruneri, IT
17:10Breast cancer clinical case discussion: parallel groups
 17:10Group 1
Maria-João Cardoso, PT - Alexandru Eniu, CH - Fady B. Geara, LB
 17:10Group 2
Evgeniya Kharchenko, RU - Fedro Alessandro Peccatori, IT
 17:10Group 3
Tõnis Metsaots, EE - Olivia Pagani, CH - Giancarlo Pruneri, IT

10 July

8:30Spotlight session - Management of NHLs
Anastasios Stathis, CH
9:00Spotlight session - Neuroendocrine tumors
Christos Toumpanakis, UK
9:30Spotlight session - Introduction to rare cancers
10:00Coffee break
10:30Clinical session - GASTROINTESTINAL CANCERS (part 1)
Anneli Elme, EE - Florian Lordick, DE
 10:30Adjuvant treatment for stage II-III colon cancer
Demetris Papamichael, CY
 11:10Systemic treatment in advanced colon cancer
Florian Lordick, DE
 11:50Multimodal management of localized rectal cancer
Demetris Papamichael, CY
12:30Lunch with the experts
13:30Clinical session - GASTROINTESTINAL CANCERS (part 2)
Anneli Elme, EE - Florian Lordick, DE
 13:30Systemic treatment of advanced/metastatic gastric cancer
Florian Lordick, DE
 14:10Management of pancreatic cancer
Sara De Dosso, CH
14:50Tumor Board on Gastrointestinal Cancer Cases (4 cases)
Sara De Dosso, CH - Anneli Elme, EE - Florian Lordick, DE - Demetris Papamichael, CY
16:00Gastrointestinal cancer clinical case discussion: parallel groups
 16:00Group 1
Sara De Dosso, CH - Demetris Papamichael, CY
 16:00Group 2
Anneli Elme, EE - Florian Lordick, DE
20:00Farewell Dinner

11 July

8:30Spotlight session - Modern management of melanoma
Salvador E. Martin Algarra, ES
9:00Spotlight session - Immune check point inhibitors: Immunologic background, indications and targeted treatment
Salvador E. Martin Algarra, ES
9:30Spotlight session - Brain tumors
Riccardo Soffietti, IT
10:00Learning Assessment Test
11:00Coffee break
11:30Announcement of LATS Results and Awards/Closing Remarks